Valuation: Abbott Laboratories

Capitalization 232B 198B 185B 171B 317B 19,906B 356B 2,216B 841B 9,286B 870B 852B 34,064B P/E ratio 2025 *
32.9x
P/E ratio 2026 * 28.9x
Enterprise value 235B 201B 188B 174B 322B 20,200B 361B 2,249B 854B 9,423B 883B 865B 34,567B EV / Sales 2025 *
5.28x
EV / Sales 2026 * 4.86x
Free-Float
86.65%
Yield 2025 *
1.79%
Yield 2026 * 1.93%
More valuation ratios * Estimated data
Dynamic Chart
1 day-1.21%
1 week-1.41%
Current month-2.79%
1 month-0.88%
3 months+4.08%
6 months+17.73%
Current year+16.90%
More quotes
1 week 131.47
Extreme 131.47
135.24
1 month 131.47
Extreme 131.47
139.06
Current year 110.86
Extreme 110.86
141.23
1 year 99.71
Extreme 99.71
141.23
3 years 89.67
Extreme 89.674
141.23
5 years 89.67
Extreme 89.674
142.6
10 years 36
Extreme 36
142.6
More quotes
Manager TitleAgeSince
Chief Executive Officer 51 2020-03-30
Director of Finance/CFO 52 2023-08-31
Chief Tech/Sci/R&D Officer - 2020-02-29
Director TitleAgeSince
Director/Board Member 74 2008-10-09
Director/Board Member 63 2011-12-08
Director/Board Member 66 2011-12-08
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-1.25%-1.41%+30.09%+21.43% 232B
-0.54%-0.04%+14.78%-0.79% 113B
-0.42%+1.82%+33.32%+109.78% 57.77B
-0.44%-1.78%-21.38%-28.55% 50.05B
+1.09%+3.45%-11.96%+41.19% 39.78B
-0.11%-0.23%-24.77%+6.32% 32.84B
+0.92%-4.67%-9.45%+19.05% 24.69B
+0.25%-0.69%+28.56%-39.87% 22.94B
-0.83%-3.32%+7.88%+10.16% 22.88B
-0.40%-2.15%+51.21%+27.86% 20.87B
Average -0.14%-1.13%+9.83%+16.66% 61.73B
Weighted average by Cap. -0.54%-0.88%+16.03%+19.45%
See all sector performances

Financials

2025 *2026 *
Net sales 44.63B 38.12B 35.58B 32.91B 61.07B 3,829B 68.42B 426B 162B 1,786B 167B 164B 6,553B 48.02B 41.01B 38.28B 35.4B 65.7B 4,119B 73.6B 459B 174B 1,922B 180B 176B 7,049B
Net income 7.19B 6.14B 5.73B 5.3B 9.84B 617B 11.02B 68.67B 26.06B 288B 26.96B 26.41B 1,056B 8.19B 7B 6.53B 6.04B 11.21B 703B 12.56B 78.27B 29.71B 328B 30.73B 30.1B 1,203B
Net Debt 3.42B 2.92B 2.73B 2.52B 4.68B 294B 5.25B 32.7B 12.41B 137B 12.84B 12.58B 503B 1.53B 1.31B 1.22B 1.13B 2.09B 131B 2.34B 14.6B 5.54B 61.16B 5.73B 5.61B 224B
More financial data * Estimated data
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Employees
114,000
Calendar
More about the company
Date Price Change Volume
25-07-09 132.78 $ -0.43% 2,096,268
25-07-08 133.36 $ -0.25% 4,782,570
25-07-07 133.70 $ -0.55% 8,927,599
25-07-03 134.44 $ +0.25% 3,114,335
25-07-02 134.11 $ -1.58% 4,319,684

Delayed Quote Nyse, July 09, 2025 at 10:27 am EDT

More quotes
Trading Rating
Investor Rating
ESG MSCI
BB
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
133.36USD
Average target price
141.51USD
Spread / Average Target
+6.11%
Consensus

Quarterly revenue - Rate of surprise